Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Retinitis pigmentosa progression tied to changes in ellipsoid zone bandwidth
  • Inherited Retinal Disease

Retinitis pigmentosa progression tied to changes in ellipsoid zone bandwidth

Kelsey Moroz

Tracking the ellipsoid zone (EZ) bandwidth annually using high-resolution spectral domain-optical coherence tomography (SD-OCT) can serve as a valuable biomarker to monitor the progression of photoreceptor degeneration and predict visual acuity outcomes in patients with retinitis pigmentosa, according to a presentation at ASRS 2024.

In the study, 66 eyes from 33 patients (10 males and 23 females, average age 28.5 years) were analyzed. A logMAR VA of 0 was found with EZ bandwidths between 1500-6000 µm. Initial visual acuity worsening (logMAR 0.1) occurred at EZ bandwidths between 900-5100 µm. Severe vision loss (logMAR 0.5-0.9) corresponded to EZ bandwidths of 0-750 µm, indicating significant foveal involvement. The central foveal EZ bandwidth declined by approximately 150 µm per year (P < 0.001), with a 5.2 µm decline for each 0.1 unit increase in logMAR scale (P < 0.001).

The authors concluded that the study suggests central foveal EZ bandwidth could be used as a biomarker to monitor photoreceptor degeneration and predict visual acuity outcomes in retinitis pigmentosa patients.

Reference
Sather R, et al. The Utilization of the Ellipsoid Zone Bandwidth and Its Correlation With Visual Acuity in Patients With Retinitis Pigmentosa. Presented at: ASRS 42nd Annual Meeting: July 17–20, 2024.

Share

Related Content

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

  • Retina

Switching to aflibercept 8 mg extends treatment intervals in suboptimal nARMD responders

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon